Treatment of Chronic Vaginal Bleeding
The levonorgestrel-releasing intrauterine device (LNG-IUD) is the most effective first-line treatment for chronic vaginal bleeding, with efficacy >99% and the added benefit of reducing menstrual blood loss. 1
First-Line Treatment Options
Levonorgestrel-releasing Intrauterine Device (LNG-IUD)
- Highly effective with typical failure rate of only 0.1-0.2% 1
- Significantly reduces menstrual bleeding volume 1, 2
- No increased risk of thrombosis 1
- Particularly beneficial for women with bleeding disorders 1
- More effective than combined oral contraceptives for reducing menstrual blood loss (OR 0.21,95% CI 0.09 to 0.48) 3
Tranexamic Acid
- Effective for acute and chronic heavy menstrual bleeding 2, 4
- Can be used in combination with hormonal methods to enhance effectiveness 1, 5
- Particularly useful for women with inherited bleeding disorders 4
- Can provide immediate improvement while waiting for hormonal treatments to take effect
Second-Line Treatment Options
Progestin-Only Methods
Progestin-Only Pills
Depot Medroxyprogesterone Acetate (DMPA)
Contraceptive Implant
Combined Hormonal Contraceptives
- Effective for treating heavy menstrual bleeding in hemodynamically stable patients 2, 3
- Options include:
- Caution: Avoid in women with risk factors for thrombosis 1
Management Algorithm for Chronic Vaginal Bleeding
Rule out structural causes (polyps, fibroids, malignancy) with appropriate imaging 2
For hemodynamically stable patients with chronic bleeding:
For acute heavy bleeding episodes:
For patients with bleeding disorders:
Special Considerations
- Women with Von Willebrand disease: LNG-IUD is preferred over DMPA due to better safety profile 1
- Women with thrombosis risk: Avoid estrogen-containing contraceptives; use progestin-only methods 1
- Persistent bleeding despite treatment: Consider adding tranexamic acid to hormonal contraception 1
- Breakthrough bleeding on hormonal methods: Consider NSAIDs, tranexamic acid, or doxycycline 6, 5
Common Pitfalls to Avoid
- Failing to rule out structural causes before initiating medical management
- Using combined hormonal contraceptives in women with thrombosis risk factors
- Not providing adequate counseling about expected bleeding patterns with different treatments
- Discontinuing treatment too early before therapeutic effect is achieved
- Not addressing breakthrough bleeding which can lead to treatment discontinuation
The choice of treatment should prioritize the LNG-IUD due to its superior efficacy in reducing menstrual blood loss while providing excellent contraception. For women who cannot use the LNG-IUD, a stepwise approach using other progestin-only methods or tranexamic acid is recommended.